Recent Studies Reveal Optimal Medication Strategies for Joint Replacement Surgery
Hospital for Special Surgery (HSS), a leading academic medical center specializing in musculoskeletal health, has released findings from several studies examining the use of targeted medications to improve outcomes for patients undergoing hip and knee replacement surgery. The research, presented at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), focuses on optimizing perioperative medication management to enhance recovery, safety and long-term results.
Aspirin Shows Promise in Reducing Postoperative Pain After Knee Replacement
A study comparing aspirin to more potent blood thinners in patients undergoing total knee arthroplasty (TKA) suggests aspirin may be the preferred option for managing postoperative pain. The research, encompassing 28,169 patients treated between 2016 and 2023, found that those receiving aspirin (18,413 patients) experienced less pain and complications compared to those on more potent blood thinners (9,756 patients) over a 90-day monitoring period.
“Patients on more-potent blood thinners tend to experience more pain, swelling and inflammation after surgery,” explained Brian P. Chalmers, MD, a hip and knee surgeon at HSS and a study author. “Our data show there is less risk and less postoperative pain when these patients are utilizing aspirin.”
NSAIDs May Be Safe to Use Alongside Anticoagulants After Hip Replacement
Another study evaluated the effects of combining nonsteroidal anti-inflammatory drugs (NSAIDs) with anticoagulants in 5,881 total hip arthroplasty patients. Researchers found that the concomitant use of NSAIDs did not increase the risk of wound-related bleeding complications. In fact, patients taking both NSAIDs and anticoagulants (4,867 patients) reported less pain and a somewhat easier recovery compared to those receiving anticoagulation alone (1,040 patients).
“NSAIDs appear to be safe in this setting and may aid decrease postoperative pain and reduce opioid use following surgery,” Dr. Chalmers stated.
Cefazolin Safe for Patients with Cephalosporin Allergies
A third study addressed the safety of using cefazolin, an antibiotic, in patients with documented cephalosporin allergies. Researchers analyzed data from 89,993 hip and knee arthroplasty patients (including 1,267 with a documented allergy) between 2016 and 2024. The study found zero instances of IgE-mediated or severe type IV allergic reactions when cefazolin was administered.
“When patients have a mild allergic reaction, there is often a reflex to grant them another antibiotic in a different family of drugs. However, alternative options aren’t always as effective,” said Matthew S. Austin, MD, hip and knee surgeon at HSS and a study author. “Clear protocols should be put in place to guide decision-making when managing these types of allergies.”
HSS Continues to Advance Perioperative Care Through Research
These findings demonstrate HSS’s dedication to refining perioperative care through data-driven research. The studies highlight the potential of targeted medication strategies to improve safety, reduce complications, and enhance outcomes for patients undergoing hip and knee arthroplasty.
Study Details:
- “Aspirin Versus Potent VTE Chemoprophylaxis in Total Knee Arthroplasty: Reduced Postoperative Pain and Complications with Aspirin Use” – Alex Anatone, Alexis Gabriel Gonzalez, Richard Hwang, David Andrew Kolin, Aaron Ira Weinblatt, Amar S Ranawat, Alejandro Gonzalez Della Valle, Brian Chalmers
- “The Effect of Concomitant Use of Potent Anticoagulation and Anti-Inflammatories on Early Outcomes of Total Hip Arthroplasty” – Alexis Gabriel Gonzalez, Aaron Ira Weinblatt, Agnes Cororaton Jones, Stephen Lyman, Richard Hwang, Alex Anatone, Carlo Marega, Alejandro Gonzalez Della Valle, Brian Chalmers
- “Cefazolin and the R-1 Side Chain: Why Your Joint Arthroplasty Patients With Cephalosporin Allergy Can Safely Be Given Cefazolin” – Josef Jolissaint, Katherine E Mallett, Andrew Thomson, Alberto V Carli, Matthew Austin